Daiichi Sankyo is a pharmaceutical company originating in Japan. It researches, develops, manufactures and markets prescription medicines, with oncology at the center of its strategy and additional products in cardiovascular and other fields. Its medicines are supplied to patients through healthcare systems in more than 30 countries and regions.
Flagship products include the antibody-drug conjugates Enhertu and Datroway, while Lixiana, Vanflyta and other therapies broaden its portfolio. In fiscal 2025 (ended March 31, 2026) the group reported revenue of ¥2,123.0 billion and had 20,171 employees.
0
open positions at Daiichi Sankyo
No live listings from Daiichi Sankyo right now — browse all Tokyo software jobs instead.